Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-d-glucose positron emission tomography: a preliminary report View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2008-06

AUTHORS

Takashi Terauchi, Takeshi Murano, Hiromitsu Daisaki, Daisuke Kanou, Hiroko Shoda, Ryutaro Kakinuma, Chisato Hamashima, Noriyuki Moriyama, Tadao Kakizoe

ABSTRACT

OBJECTIVE: (18)F-2-deoxy-2-fluoro-D-glucose positron emission tomography (FDG-PET) is a promising screening modality targeting whole body. However, the validity of PET cancer screening remains to be assessed. Even the screening accuracy for whole-body screening using FDG-PET has not been evaluated. In this study, we investigated the screening accuracy of PET cancer screening. METHODS: A total of 2911 asymptomatic participants (1629 men and 1282 women, mean age 59.79 years) underwent both FDG-PET and other thorough examinations for multiple organs (gastrofiberscopy, total colonofiberscopy or barium enema, low-dose thin section computed tomography and sputum cytology, abdominal ultrasonography, an assay of prostate-specific antigen, mammography, mammary ultrasonography, Pap smear for the uterine cervix, and magnetic resonance imaging for the endometrium and ovaries) between February 2004 and January 2005, and followed sufficiently. The detection rate, sensitivity, specificity, and positive predictive value of FDG-PET were calculated using cancer data obtained from all examinations along with a 1 year follow-up. RESULTS: From among 2911 participants FDG-PET found 28 cancers, 129 cancers were PET negative. PET-positive cancers comprised seven colorectal cancers, four lung cancers, four thyroid cancers, three breast cancers, two gastric cancers, two prostate cancers, two small intestinal sarcomas (gastrointestinal stromal tumors), one malignant lymphoma, one head and neck malignancy (nasopharyngeal carcinoid tumor), one thymoma, and one hepatocellular carcinoma. PET-negative cancers included 22 gastric cancers and 20 prostate cancers that were essentially difficult to detect using FDG-PET. The overall detection rate, sensitivity, specificity, and positive predictive value were estimated to be 0.96%, 17.83%, 95.15%, and 11.20%, respectively. CONCLUSIONS: FDG-PET can detect a variety of cancers at an early stage as part of a whole-body screening modality. The detection rate of PET cancer screening was higher than that of other screening modalities, which had already shown evidence of efficacy. However, the sensitivity of PET cancer screening was lower than that of other thorough examinations performed at our institute. FDG-PET has some limitations, and cancer screening using only FDG-PET is likely to miss some cancers. More... »

PAGES

379-385

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12149-008-0130-7

DOI

http://dx.doi.org/10.1007/s12149-008-0130-7

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1018700718

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18600415


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorodeoxyglucose F18", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mass Screening", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pilot Projects", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radionuclide Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sensitivity and Specificity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Whole Body Imaging", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Terauchi", 
        "givenName": "Takashi", 
        "id": "sg:person.0766725261.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766725261.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murano", 
        "givenName": "Takeshi", 
        "id": "sg:person.01215532117.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215532117.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Daisaki", 
        "givenName": "Hiromitsu", 
        "id": "sg:person.0704464201.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704464201.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kanou", 
        "givenName": "Daisuke", 
        "id": "sg:person.0645165315.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645165315.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shoda", 
        "givenName": "Hiroko", 
        "id": "sg:person.0713300515.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713300515.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kakinuma", 
        "givenName": "Ryutaro", 
        "id": "sg:person.010057331517.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010057331517.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Screening Assessment and Management Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hamashima", 
        "givenName": "Chisato", 
        "id": "sg:person.01027527115.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027527115.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moriyama", 
        "givenName": "Noriyuki", 
        "id": "sg:person.01062144612.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062144612.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.272242.3", 
          "name": [
            "National Cancer Center, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kakizoe", 
        "givenName": "Tadao", 
        "id": "sg:person.01337610735.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337610735.59"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(19970215)79:4<695::aid-cncr6>3.0.co;2-d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002320901"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1054/bjoc.2000.1496", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008190941", 
          "https://doi.org/10.1054/bjoc.2000.1496"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf01249629", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016456637", 
          "https://doi.org/10.1007/bf01249629"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03034001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018059579", 
          "https://doi.org/10.1007/bf03034001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03034001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018059579", 
          "https://doi.org/10.1007/bf03034001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0959-8049(95)00421-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029421313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12149-007-0061-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036979330", 
          "https://doi.org/10.1007/s12149-007-0061-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03164996", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039404426", 
          "https://doi.org/10.1007/bf03164996"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03164996", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039404426", 
          "https://doi.org/10.1007/bf03164996"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/(sici)1097-0142(19980601)82:11<2227::aid-cncr18>3.0.co;2-w", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039814517"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0749-3797(01)00261-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041656773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1442-2042.2002.00416.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043008165"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0001-2998(96)80006-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046867727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.285.7.914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047716064"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02984601", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050431834", 
          "https://doi.org/10.1007/bf02984601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02984601", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050431834", 
          "https://doi.org/10.1007/bf02984601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hyl022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052475020"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-2000-9875", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057405567"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2003-030465", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064286866"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074508177", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077689341", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082413673", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083278017", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2008-06", 
    "datePublishedReg": "2008-06-01", 
    "description": "OBJECTIVE: (18)F-2-deoxy-2-fluoro-D-glucose positron emission tomography (FDG-PET) is a promising screening modality targeting whole body. However, the validity of PET cancer screening remains to be assessed. Even the screening accuracy for whole-body screening using FDG-PET has not been evaluated. In this study, we investigated the screening accuracy of PET cancer screening.\nMETHODS: A total of 2911 asymptomatic participants (1629 men and 1282 women, mean age 59.79 years) underwent both FDG-PET and other thorough examinations for multiple organs (gastrofiberscopy, total colonofiberscopy or barium enema, low-dose thin section computed tomography and sputum cytology, abdominal ultrasonography, an assay of prostate-specific antigen, mammography, mammary ultrasonography, Pap smear for the uterine cervix, and magnetic resonance imaging for the endometrium and ovaries) between February 2004 and January 2005, and followed sufficiently. The detection rate, sensitivity, specificity, and positive predictive value of FDG-PET were calculated using cancer data obtained from all examinations along with a 1 year follow-up.\nRESULTS: From among 2911 participants FDG-PET found 28 cancers, 129 cancers were PET negative. PET-positive cancers comprised seven colorectal cancers, four lung cancers, four thyroid cancers, three breast cancers, two gastric cancers, two prostate cancers, two small intestinal sarcomas (gastrointestinal stromal tumors), one malignant lymphoma, one head and neck malignancy (nasopharyngeal carcinoid tumor), one thymoma, and one hepatocellular carcinoma. PET-negative cancers included 22 gastric cancers and 20 prostate cancers that were essentially difficult to detect using FDG-PET. The overall detection rate, sensitivity, specificity, and positive predictive value were estimated to be 0.96%, 17.83%, 95.15%, and 11.20%, respectively.\nCONCLUSIONS: FDG-PET can detect a variety of cancers at an early stage as part of a whole-body screening modality. The detection rate of PET cancer screening was higher than that of other screening modalities, which had already shown evidence of efficacy. However, the sensitivity of PET cancer screening was lower than that of other thorough examinations performed at our institute. FDG-PET has some limitations, and cancer screening using only FDG-PET is likely to miss some cancers.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12149-008-0130-7", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1099601", 
        "issn": [
          "0914-7187", 
          "1864-6433"
        ], 
        "name": "Annals of Nuclear Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "22"
      }
    ], 
    "name": "Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-d-glucose positron emission tomography: a preliminary report", 
    "pagination": "379-385", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "591a2217a2980dae0ae8de93a899b328fc96c3d3723d8c66e97a17f9c15b6945"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18600415"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8913398"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12149-008-0130-7"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1018700718"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12149-008-0130-7", 
      "https://app.dimensions.ai/details/publication/pub.1018700718"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:39", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8687_00000521.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs12149-008-0130-7"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12149-008-0130-7'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12149-008-0130-7'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12149-008-0130-7'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12149-008-0130-7'


 

This table displays all metadata directly associated to this object as RDF triples.

242 TRIPLES      21 PREDICATES      62 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12149-008-0130-7 schema:about N156581e47b9e4a4a84ecb1841eec646a
2 N2bc14c9ca1da4293bc6675252827ed2d
3 N396388648aaf4e16ba6de59d1d1afeb2
4 N45e53fd94ed94a2382a820865a3f2a69
5 N5656a58378054175b5c021a88b11013e
6 N56f3b5d75b6543dc8ef4ade3b7bdf521
7 N8009042272174fa784257374fde5597b
8 N860d65b27ee345c2b05a532b411c8aea
9 N97c8af86b24d4ae59f7ef4591fa7c643
10 Ncfe1a25a4d284958a1b65432d3975665
11 Ne0637cba58914c1ea31a88820608b919
12 Ne252519e6c87475b9d71f76252d76b45
13 Ne3881edf5ba34549a9436491b1095454
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author N40d6d0186961403a9a7c666eff4539d8
17 schema:citation sg:pub.10.1007/bf01249629
18 sg:pub.10.1007/bf02984601
19 sg:pub.10.1007/bf03034001
20 sg:pub.10.1007/bf03164996
21 sg:pub.10.1007/s12149-007-0061-8
22 sg:pub.10.1054/bjoc.2000.1496
23 https://app.dimensions.ai/details/publication/pub.1074508177
24 https://app.dimensions.ai/details/publication/pub.1077689341
25 https://app.dimensions.ai/details/publication/pub.1082413673
26 https://app.dimensions.ai/details/publication/pub.1083278017
27 https://doi.org/10.1001/jama.285.7.914
28 https://doi.org/10.1002/(sici)1097-0142(19970215)79:4<695::aid-cncr6>3.0.co;2-d
29 https://doi.org/10.1002/(sici)1097-0142(19980601)82:11<2227::aid-cncr18>3.0.co;2-w
30 https://doi.org/10.1016/0959-8049(95)00421-1
31 https://doi.org/10.1016/s0001-2998(96)80006-7
32 https://doi.org/10.1016/s0749-3797(01)00261-6
33 https://doi.org/10.1046/j.1442-2042.2002.00416.x
34 https://doi.org/10.1055/s-2000-9875
35 https://doi.org/10.1093/jjco/hyl022
36 https://doi.org/10.1210/jc.2003-030465
37 schema:datePublished 2008-06
38 schema:datePublishedReg 2008-06-01
39 schema:description OBJECTIVE: (18)F-2-deoxy-2-fluoro-D-glucose positron emission tomography (FDG-PET) is a promising screening modality targeting whole body. However, the validity of PET cancer screening remains to be assessed. Even the screening accuracy for whole-body screening using FDG-PET has not been evaluated. In this study, we investigated the screening accuracy of PET cancer screening. METHODS: A total of 2911 asymptomatic participants (1629 men and 1282 women, mean age 59.79 years) underwent both FDG-PET and other thorough examinations for multiple organs (gastrofiberscopy, total colonofiberscopy or barium enema, low-dose thin section computed tomography and sputum cytology, abdominal ultrasonography, an assay of prostate-specific antigen, mammography, mammary ultrasonography, Pap smear for the uterine cervix, and magnetic resonance imaging for the endometrium and ovaries) between February 2004 and January 2005, and followed sufficiently. The detection rate, sensitivity, specificity, and positive predictive value of FDG-PET were calculated using cancer data obtained from all examinations along with a 1 year follow-up. RESULTS: From among 2911 participants FDG-PET found 28 cancers, 129 cancers were PET negative. PET-positive cancers comprised seven colorectal cancers, four lung cancers, four thyroid cancers, three breast cancers, two gastric cancers, two prostate cancers, two small intestinal sarcomas (gastrointestinal stromal tumors), one malignant lymphoma, one head and neck malignancy (nasopharyngeal carcinoid tumor), one thymoma, and one hepatocellular carcinoma. PET-negative cancers included 22 gastric cancers and 20 prostate cancers that were essentially difficult to detect using FDG-PET. The overall detection rate, sensitivity, specificity, and positive predictive value were estimated to be 0.96%, 17.83%, 95.15%, and 11.20%, respectively. CONCLUSIONS: FDG-PET can detect a variety of cancers at an early stage as part of a whole-body screening modality. The detection rate of PET cancer screening was higher than that of other screening modalities, which had already shown evidence of efficacy. However, the sensitivity of PET cancer screening was lower than that of other thorough examinations performed at our institute. FDG-PET has some limitations, and cancer screening using only FDG-PET is likely to miss some cancers.
40 schema:genre research_article
41 schema:inLanguage en
42 schema:isAccessibleForFree false
43 schema:isPartOf N92c5e9b45a9c4239a0ed7cc455f8b31e
44 Nafb5f36fb4e744edb8b507912e172c3f
45 sg:journal.1099601
46 schema:name Evaluation of whole-body cancer screening using 18F-2-deoxy-2-fluoro-d-glucose positron emission tomography: a preliminary report
47 schema:pagination 379-385
48 schema:productId N1ac5f1ea05b04153a5a7a526db085a0a
49 Na35755fd96fa49b7bb3920dfdd4db79e
50 Na97a8ca9538240bca021bcdfd10c6d0a
51 Nd65ea280bcb44a5e8405327801f358b5
52 Ne61cc1741b2e459892383dfd0e5303ed
53 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018700718
54 https://doi.org/10.1007/s12149-008-0130-7
55 schema:sdDatePublished 2019-04-10T21:39
56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
57 schema:sdPublisher N41c656f01f534c63b6ec243d8dd430a1
58 schema:url http://link.springer.com/10.1007%2Fs12149-008-0130-7
59 sgo:license sg:explorer/license/
60 sgo:sdDataset articles
61 rdf:type schema:ScholarlyArticle
62 N0377993ed2d547f18afdbab98573e72b rdf:first sg:person.01062144612.81
63 rdf:rest N87803ca7e3f741279cc47fe22aa7f0d0
64 N156581e47b9e4a4a84ecb1841eec646a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Radiopharmaceuticals
66 rdf:type schema:DefinedTerm
67 N1ac5f1ea05b04153a5a7a526db085a0a schema:name dimensions_id
68 schema:value pub.1018700718
69 rdf:type schema:PropertyValue
70 N2bc14c9ca1da4293bc6675252827ed2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Male
72 rdf:type schema:DefinedTerm
73 N396388648aaf4e16ba6de59d1d1afeb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Reproducibility of Results
75 rdf:type schema:DefinedTerm
76 N40d6d0186961403a9a7c666eff4539d8 rdf:first sg:person.0766725261.48
77 rdf:rest N570c5d8b5846432b87bc5aa6d78d2db0
78 N41c656f01f534c63b6ec243d8dd430a1 schema:name Springer Nature - SN SciGraph project
79 rdf:type schema:Organization
80 N45e53fd94ed94a2382a820865a3f2a69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Female
82 rdf:type schema:DefinedTerm
83 N473f2cdc13e0415fa7a20d933e037d74 rdf:first sg:person.01027527115.88
84 rdf:rest N0377993ed2d547f18afdbab98573e72b
85 N5656a58378054175b5c021a88b11013e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Middle Aged
87 rdf:type schema:DefinedTerm
88 N56f3b5d75b6543dc8ef4ade3b7bdf521 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Mass Screening
90 rdf:type schema:DefinedTerm
91 N570c5d8b5846432b87bc5aa6d78d2db0 rdf:first sg:person.01215532117.70
92 rdf:rest N9ca449ca020b425886efd354572c9b7e
93 N5c6dfd8938094be2a74c3cd862831932 rdf:first sg:person.0713300515.45
94 rdf:rest Nd82cdc006a4344d5a88d1d8ea39c9a77
95 N8009042272174fa784257374fde5597b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Sensitivity and Specificity
97 rdf:type schema:DefinedTerm
98 N860d65b27ee345c2b05a532b411c8aea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Whole Body Imaging
100 rdf:type schema:DefinedTerm
101 N87803ca7e3f741279cc47fe22aa7f0d0 rdf:first sg:person.01337610735.59
102 rdf:rest rdf:nil
103 N92c5e9b45a9c4239a0ed7cc455f8b31e schema:issueNumber 5
104 rdf:type schema:PublicationIssue
105 N97c8af86b24d4ae59f7ef4591fa7c643 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Neoplasms
107 rdf:type schema:DefinedTerm
108 N9ca449ca020b425886efd354572c9b7e rdf:first sg:person.0704464201.36
109 rdf:rest Nac728aa8a3e3484796f803364e6b396d
110 Na35755fd96fa49b7bb3920dfdd4db79e schema:name nlm_unique_id
111 schema:value 8913398
112 rdf:type schema:PropertyValue
113 Na97a8ca9538240bca021bcdfd10c6d0a schema:name doi
114 schema:value 10.1007/s12149-008-0130-7
115 rdf:type schema:PropertyValue
116 Nac728aa8a3e3484796f803364e6b396d rdf:first sg:person.0645165315.21
117 rdf:rest N5c6dfd8938094be2a74c3cd862831932
118 Nafb5f36fb4e744edb8b507912e172c3f schema:volumeNumber 22
119 rdf:type schema:PublicationVolume
120 Ncfe1a25a4d284958a1b65432d3975665 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Humans
122 rdf:type schema:DefinedTerm
123 Nd65ea280bcb44a5e8405327801f358b5 schema:name readcube_id
124 schema:value 591a2217a2980dae0ae8de93a899b328fc96c3d3723d8c66e97a17f9c15b6945
125 rdf:type schema:PropertyValue
126 Nd82cdc006a4344d5a88d1d8ea39c9a77 rdf:first sg:person.010057331517.03
127 rdf:rest N473f2cdc13e0415fa7a20d933e037d74
128 Ne0637cba58914c1ea31a88820608b919 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Pilot Projects
130 rdf:type schema:DefinedTerm
131 Ne252519e6c87475b9d71f76252d76b45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Radionuclide Imaging
133 rdf:type schema:DefinedTerm
134 Ne3881edf5ba34549a9436491b1095454 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Fluorodeoxyglucose F18
136 rdf:type schema:DefinedTerm
137 Ne61cc1741b2e459892383dfd0e5303ed schema:name pubmed_id
138 schema:value 18600415
139 rdf:type schema:PropertyValue
140 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
141 schema:name Medical and Health Sciences
142 rdf:type schema:DefinedTerm
143 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
144 schema:name Oncology and Carcinogenesis
145 rdf:type schema:DefinedTerm
146 sg:journal.1099601 schema:issn 0914-7187
147 1864-6433
148 schema:name Annals of Nuclear Medicine
149 rdf:type schema:Periodical
150 sg:person.010057331517.03 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
151 schema:familyName Kakinuma
152 schema:givenName Ryutaro
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010057331517.03
154 rdf:type schema:Person
155 sg:person.01027527115.88 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
156 schema:familyName Hamashima
157 schema:givenName Chisato
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01027527115.88
159 rdf:type schema:Person
160 sg:person.01062144612.81 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
161 schema:familyName Moriyama
162 schema:givenName Noriyuki
163 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01062144612.81
164 rdf:type schema:Person
165 sg:person.01215532117.70 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
166 schema:familyName Murano
167 schema:givenName Takeshi
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215532117.70
169 rdf:type schema:Person
170 sg:person.01337610735.59 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
171 schema:familyName Kakizoe
172 schema:givenName Tadao
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01337610735.59
174 rdf:type schema:Person
175 sg:person.0645165315.21 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
176 schema:familyName Kanou
177 schema:givenName Daisuke
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645165315.21
179 rdf:type schema:Person
180 sg:person.0704464201.36 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
181 schema:familyName Daisaki
182 schema:givenName Hiromitsu
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704464201.36
184 rdf:type schema:Person
185 sg:person.0713300515.45 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
186 schema:familyName Shoda
187 schema:givenName Hiroko
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713300515.45
189 rdf:type schema:Person
190 sg:person.0766725261.48 schema:affiliation https://www.grid.ac/institutes/grid.272242.3
191 schema:familyName Terauchi
192 schema:givenName Takashi
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766725261.48
194 rdf:type schema:Person
195 sg:pub.10.1007/bf01249629 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016456637
196 https://doi.org/10.1007/bf01249629
197 rdf:type schema:CreativeWork
198 sg:pub.10.1007/bf02984601 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050431834
199 https://doi.org/10.1007/bf02984601
200 rdf:type schema:CreativeWork
201 sg:pub.10.1007/bf03034001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018059579
202 https://doi.org/10.1007/bf03034001
203 rdf:type schema:CreativeWork
204 sg:pub.10.1007/bf03164996 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039404426
205 https://doi.org/10.1007/bf03164996
206 rdf:type schema:CreativeWork
207 sg:pub.10.1007/s12149-007-0061-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036979330
208 https://doi.org/10.1007/s12149-007-0061-8
209 rdf:type schema:CreativeWork
210 sg:pub.10.1054/bjoc.2000.1496 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008190941
211 https://doi.org/10.1054/bjoc.2000.1496
212 rdf:type schema:CreativeWork
213 https://app.dimensions.ai/details/publication/pub.1074508177 schema:CreativeWork
214 https://app.dimensions.ai/details/publication/pub.1077689341 schema:CreativeWork
215 https://app.dimensions.ai/details/publication/pub.1082413673 schema:CreativeWork
216 https://app.dimensions.ai/details/publication/pub.1083278017 schema:CreativeWork
217 https://doi.org/10.1001/jama.285.7.914 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047716064
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1002/(sici)1097-0142(19970215)79:4<695::aid-cncr6>3.0.co;2-d schema:sameAs https://app.dimensions.ai/details/publication/pub.1002320901
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1002/(sici)1097-0142(19980601)82:11<2227::aid-cncr18>3.0.co;2-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1039814517
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/0959-8049(95)00421-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029421313
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/s0001-2998(96)80006-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046867727
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1016/s0749-3797(01)00261-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041656773
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1046/j.1442-2042.2002.00416.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043008165
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1055/s-2000-9875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057405567
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1093/jjco/hyl022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052475020
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1210/jc.2003-030465 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064286866
236 rdf:type schema:CreativeWork
237 https://www.grid.ac/institutes/grid.272242.3 schema:alternateName National Cancer Centre
238 schema:name National Cancer Center, Tokyo, Japan
239 Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan
240 Screening Assessment and Management Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan
241 Screening Technology and Development Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, 104-0045, Tokyo, Japan
242 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...